Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Expression of podoplanin and prognosis in oropharyngeal cancer.

Preuss SF, Anagiotos A, Seuthe IM, Drebber U, Wedemeyer I, Kreppel M, Semrau R, Eslick GD, Klussmann JP, Huebbers CU.

Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1749-54. doi: 10.1007/s00405-014-3105-4. Epub 2014 Jun 1.

PMID:
24880471
2.

Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.

Huber GF, Fritzsche FR, Züllig L, Storz M, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H.

Int J Cancer. 2011 Sep 15;129(6):1404-9. doi: 10.1002/ijc.25795. Epub 2011 Feb 11.

3.

Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.

Wakisaka N, Yoshida S, Kondo S, Kita M, Sawada-Kitamura S, Endo K, Tsuji A, Nakanish Y, Murono S, Yoshizaki T.

Histopathology. 2015 May;66(6):771-80. doi: 10.1111/his.12496. Epub 2014 Nov 10.

PMID:
25039283
4.

Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.

Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Sobande FA, Ryska A.

Neoplasma. 2012;59(4):398-408. doi: 10.4149/neo_2012_052.

PMID:
22489695
5.

Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.

Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G, Heiland M, Blessmann M.

J Oral Pathol Med. 2013 Oct;42(9):676-81. doi: 10.1111/jop.12086. Epub 2013 May 31.

PMID:
23721566
6.

Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations.

Kreppel M, Scheer M, Drebber U, Ritter L, Zöller JE.

Virchows Arch. 2010 May;456(5):473-82. doi: 10.1007/s00428-010-0915-7.

PMID:
20393745
7.

Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.

Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, Imai Y, Usami Y.

Jpn J Clin Oncol. 2014 Mar;44(3):232-40. doi: 10.1093/jjco/hyt223. Epub 2014 Jan 26.

PMID:
24470584
8.

Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.

Kreppel M, Krakowezki A, Kreppel B, Drebber U, Wedemeyer I, Mauch C, Zöller JE, Scheer M.

J Surg Oncol. 2013 Mar;107(4):376-83. doi: 10.1002/jso.23238. Epub 2012 Aug 6.

PMID:
22886751
9.

Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.

Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, Umeda M, Asahina I, Ikeda T.

Pathol Oncol Res. 2014 Jul;20(3):521-8. doi: 10.1007/s12253-013-9723-0. Epub 2013 Nov 28.

PMID:
24281769
10.

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.

Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L.

Cancer. 2006 Aug 1;107(3):563-9.

11.

Podoplanin expressing cancer-associated fibroblasts in oral cancer.

Inoue H, Tsuchiya H, Miyazaki Y, Kikuchi K, Ide F, Sakashita H, Kusama K.

Tumour Biol. 2014 Nov;35(11):11345-52. doi: 10.1007/s13277-014-2450-7. Epub 2014 Aug 14.

PMID:
25119595
12.

[Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].

Zhang G, Guo ZL, Gao Y.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2009 Aug;44(8):488-91. Chinese.

PMID:
19961757
13.

Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.

Tong L, Yuan S, Feng F, Zhang H.

Dis Esophagus. 2012 Jan;25(1):72-80. doi: 10.1111/j.1442-2050.2011.01211.x. Epub 2011 Sep 2.

PMID:
21895849
14.

Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

de Vicente JC, Santamarta TR, Rodrigo JP, García-Pedrero JM, Allonca E, Blanco-Lorenzo V.

Virchows Arch. 2015 May;466(5):549-58. doi: 10.1007/s00428-015-1746-3. Epub 2015 Mar 1.

PMID:
25726183
15.

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.

Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L.

J Clin Oncol. 2008 Jan 20;26(3):354-60. doi: 10.1200/JCO.2007.13.4072.

PMID:
18202409
16.

Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.

dos Santos Almeida A, Oliveira DT, Pereira MC, Faustino SE, Nonogaki S, Carvalho AL, Kowalski LP.

Anticancer Res. 2013 Sep;33(9):3969-76.

PMID:
24023336
17.

Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.

Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez-Campo FJ.

J Oral Maxillofac Surg. 2010 Feb;68(2):268-75. doi: 10.1016/j.joms.2009.09.071.

PMID:
20116694
18.

Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors.

Klozar J, Koslabova E, Kratochvil V, Salakova M, Tachezy R.

J Surg Oncol. 2013 May;107(6):625-33. doi: 10.1002/jso.23292. Epub 2012 Nov 28.

PMID:
23192334
19.

Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.

Kreppel M, Drebber U, Wedemeyer I, Eich HT, Backhaus T, Zöller JE, Scheer M.

Oral Oncol. 2011 Sep;47(9):873-8. doi: 10.1016/j.oraloncology.2011.06.508. Epub 2011 Jul 20.

PMID:
21767977
20.

[Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].

Huang H, Zhang B, Chen W, Zou SM, Xu ZG.

Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):684-8. Chinese.

PMID:
24332056

Supplemental Content

Support Center